![Novavax, eyeing the COVID 'vaccine hesitant' and kids, unveils new education campaigns as Nuvaxovid nears US finish line | Fierce Pharma Novavax, eyeing the COVID 'vaccine hesitant' and kids, unveils new education campaigns as Nuvaxovid nears US finish line | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/Novavaximage.png?VersionId=f9UDAFMgagg4Y_igFXWmnc3TJKOoTl_k)
Novavax, eyeing the COVID 'vaccine hesitant' and kids, unveils new education campaigns as Nuvaxovid nears US finish line | Fierce Pharma
Novavax Inks Deal With India's Serum Institute To Make Coronavirus Vaccine Available In Low, Middle Income Countries
![Novavax on X: "We've got big news. Our protein-based #COVID19vaccine is now authorized for 18+ primary series under emergency use in the United States. [🧵1 of 2] Read more: https://t.co/n9Ddg0ozAa https://t.co/B0FTrxlKMr" / Novavax on X: "We've got big news. Our protein-based #COVID19vaccine is now authorized for 18+ primary series under emergency use in the United States. [🧵1 of 2] Read more: https://t.co/n9Ddg0ozAa https://t.co/B0FTrxlKMr" /](https://pbs.twimg.com/media/FXk8KBIXoAIMrHQ.jpg)
Novavax on X: "We've got big news. Our protein-based #COVID19vaccine is now authorized for 18+ primary series under emergency use in the United States. [🧵1 of 2] Read more: https://t.co/n9Ddg0ozAa https://t.co/B0FTrxlKMr" /
![Novavax on X: "RELEASE: Novavax Publishes Results of United Kingdom Phase 3 Clinical Trial in @NEJM, Demonstrating High Levels of Efficacy of #COVID19 Vaccine https://t.co/uUgpHcyuY1 https://t.co/nbCjELUwJF" / X Novavax on X: "RELEASE: Novavax Publishes Results of United Kingdom Phase 3 Clinical Trial in @NEJM, Demonstrating High Levels of Efficacy of #COVID19 Vaccine https://t.co/uUgpHcyuY1 https://t.co/nbCjELUwJF" / X](https://pbs.twimg.com/media/E5KSAsCXIAMgNuF.jpg)
Novavax on X: "RELEASE: Novavax Publishes Results of United Kingdom Phase 3 Clinical Trial in @NEJM, Demonstrating High Levels of Efficacy of #COVID19 Vaccine https://t.co/uUgpHcyuY1 https://t.co/nbCjELUwJF" / X
![OR Health Authority on X: "The Novavax #COVID19 vaccine is now available in Oregon. Supply is limited. Check https://t.co/YbkKOGSP0W to search for locations around Oregon that may have Novavax in stock. https://t.co/CFMQnUz6Z5" / OR Health Authority on X: "The Novavax #COVID19 vaccine is now available in Oregon. Supply is limited. Check https://t.co/YbkKOGSP0W to search for locations around Oregon that may have Novavax in stock. https://t.co/CFMQnUz6Z5" /](https://pbs.twimg.com/media/FY7EyraWYAEw6cn.png)
OR Health Authority on X: "The Novavax #COVID19 vaccine is now available in Oregon. Supply is limited. Check https://t.co/YbkKOGSP0W to search for locations around Oregon that may have Novavax in stock. https://t.co/CFMQnUz6Z5" /
![Novavax on X: "Novavax, Inc. (Nasdaq: NVAX), announced it will report its first quarter 2023 financial results and operational highlights at 8:30 a.m. EDT on Tuesday, May 9, 2023. Details: https://t.co/JbtO2mnbIE https://t.co/WYqwQ3TeIY" / Novavax on X: "Novavax, Inc. (Nasdaq: NVAX), announced it will report its first quarter 2023 financial results and operational highlights at 8:30 a.m. EDT on Tuesday, May 9, 2023. Details: https://t.co/JbtO2mnbIE https://t.co/WYqwQ3TeIY" /](https://pbs.twimg.com/ext_tw_video_thumb/1653817558963724298/pu/img/M9_I3d1NlbwliWoa.jpg)
Novavax on X: "Novavax, Inc. (Nasdaq: NVAX), announced it will report its first quarter 2023 financial results and operational highlights at 8:30 a.m. EDT on Tuesday, May 9, 2023. Details: https://t.co/JbtO2mnbIE https://t.co/WYqwQ3TeIY" /
![Social Media: Graphics Explaining How the Novavax Vaccine Can Help (English, Spanish) | Vaccine Resource Hub Social Media: Graphics Explaining How the Novavax Vaccine Can Help (English, Spanish) | Vaccine Resource Hub](https://vaccineresourcehub.org/sites/default/files/resources/thumbnails/Novavax%20thumbnail.png)
Social Media: Graphics Explaining How the Novavax Vaccine Can Help (English, Spanish) | Vaccine Resource Hub
![Novavax on X: "This Thanksgiving, we're thankful for the tens of thousands of Novavax clinical trial participants around the world. Thank you! https://t.co/cFsdYQT2Pf" / X Novavax on X: "This Thanksgiving, we're thankful for the tens of thousands of Novavax clinical trial participants around the world. Thank you! https://t.co/cFsdYQT2Pf" / X](https://pbs.twimg.com/media/FFCaqOVXwAkt9iS.jpg)
Novavax on X: "This Thanksgiving, we're thankful for the tens of thousands of Novavax clinical trial participants around the world. Thank you! https://t.co/cFsdYQT2Pf" / X
![Novavax on X: "ICYMI: We recently announced results that expand our knowledge of NVX-CoV2373 and its ability to help protect from COVID19 over a longer period of time. Let's talk about what Novavax on X: "ICYMI: We recently announced results that expand our knowledge of NVX-CoV2373 and its ability to help protect from COVID19 over a longer period of time. Let's talk about what](https://pbs.twimg.com/media/FNhIrhtWUAQTNCf.jpg:large)
Novavax on X: "ICYMI: We recently announced results that expand our knowledge of NVX-CoV2373 and its ability to help protect from COVID19 over a longer period of time. Let's talk about what
![What You Need to Know About the Novavax Protein-Based Vaccine | Johns Hopkins | Bloomberg School of Public Health What You Need to Know About the Novavax Protein-Based Vaccine | Johns Hopkins | Bloomberg School of Public Health](https://publichealth.jhu.edu/sites/default/files/styles/social_image/public/2022-06/novavax-g1239401713-editorial.jpeg?itok=3s8FBzub)
What You Need to Know About the Novavax Protein-Based Vaccine | Johns Hopkins | Bloomberg School of Public Health
![Novavax on X: "Novavax is prepared to deliver protein-based monovalent XBB COVID Vaccine Consistent with FDA VRBPAC recommendation for the fall https://t.co/xnd3gOX1sc https://t.co/fGZhV6swiA" / X Novavax on X: "Novavax is prepared to deliver protein-based monovalent XBB COVID Vaccine Consistent with FDA VRBPAC recommendation for the fall https://t.co/xnd3gOX1sc https://t.co/fGZhV6swiA" / X](https://pbs.twimg.com/ext_tw_video_thumb/1669459950609858564/pu/img/njoOgX4SIX47xKKV.jpg:large)
Novavax on X: "Novavax is prepared to deliver protein-based monovalent XBB COVID Vaccine Consistent with FDA VRBPAC recommendation for the fall https://t.co/xnd3gOX1sc https://t.co/fGZhV6swiA" / X
![Novavax on X: "The World Health Organization (@WHO) grants second Emergency Use Listing (EUL) for Novavax' COVID-19 Vaccine. https://t.co/DmBkx3C8d2" / X Novavax on X: "The World Health Organization (@WHO) grants second Emergency Use Listing (EUL) for Novavax' COVID-19 Vaccine. https://t.co/DmBkx3C8d2" / X](https://pbs.twimg.com/media/FHEWj3SX0Aw0yLa.jpg:large)